LifeMD to Report Third Quarter 2025 Financial Results on November 6
LifeMD (Nasdaq: LFMD) will report financial results for the three and nine months ended September 30, 2025 after U.S. market close on November 6, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LifeMD (Nasdaq: LFMD) will report financial results for the three and nine months ended September 30, 2025 after U.S. market close on November 6, 2025. The company will host a conference call and webcast beginning at 4:30 p.m. Eastern time the same day.
Conference call dial-in and webcast details: toll-free 800-245-3047, international 203-518-9765, conference ID LIFEMD, and a live & archived webcast link will be available.
Details
News Market Reaction – LFMD
On Oct 23, the day this news came out, LFMD closed 1.30% above the previous close.
Data tracked by StockTitan Argus for the Oct 23 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and nine months ended September 30, 2025 after the close of the U.S. financial markets on November 6, 2025, and will host a conference call beginning at 4:30 p.m. Eastern time.
Conference Call & Webcast Details
| Date: | Thursday, November 6th |
| Time: | 4:30 p.m. Eastern time |
| Toll-Free Dial-In: | 800-245-3047 |
| International Dial-In: | 203-518-9765 |
| Conference ID: | LIFEMD |
| Live & Archived Webcast: | Link |
About LifeMD, Inc.
LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.
Investor Contact
Marc Benathen, Chief Financial Officer
marc@lifemd.com
Media Contact
Jessica Friedeman, Chief Marketing and Product Officer
press@lifemd.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.